Andere talen Evaxion Biotech A/S

Aandelen

EVAX

US29970R2040

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 22-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
4,19 ^USD	-2,78%		+2,20%	-38,89%

17/04	Evaxion kondigt Fase 2 Klinische Studie Update aan	CI
11/04	Europese aandelen verhandeld in de VS als American Depositary Receipts dalen in de handel van donderdag	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Evaxion Announces Phase 2 Clinical Trial Update	17/04
Evaxion Announces Phase 2 Clinical Trial Update: First Patient Completed Dosing with Personalized Cancer Vaccine EVX-01	17/04
European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading	11/04
European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading	09/04
European Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading	08/04
Certain Warrants of Evaxion Biotech A/S are subject to a Lock-Up Agreement Ending on 7-APR-2024.	07/04
Certain American Depositary Shares of Evaxion Biotech A/S are subject to a Lock-Up Agreement Ending on 7-APR-2024.	07/04
Certain Ordinary Shares of Evaxion Biotech A/S are subject to a Lock-Up Agreement Ending on 7-APR-2024.	07/04
European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading, Close Out Week Lower	05/04
European Equities Traded in the US as American Depositary Receipts Trend Higher in Wednesday Trading	03/04
ADRs End Lower; Meta Data Slides 22%	02/04
Sector Update: Health Care Stocks Slide Late Afternoon	02/04
Sector Update: Health Care Stocks Slipping in Afternoon Trading	02/04
Evaxion's EVX-B1 Vaccine Shows Promising Protection Against Staph Infections in Preclinical Studies; Shares Jump	02/04
Evaxion and Undisclosed Collaborator Announce Encouraging Results for EVX-B1 Vaccine Antigens Against Staphylococcus Aureus Infection	02/04
Evaxion and Undisclosed Collaborator Announce Encouraging Results for Evx-B1 Vaccine Antigens Against Staphylococcus Aureus Infection	02/04
16 APRIL 2024 AT 15:00 (CEST) - Form 6-K	29/03
European Equities Traded in the US as American Depositary Receipts Slightly Higher Thursday	28/03
European Equities Traded in the US as American Depositary Receipts Rise Slightly in Wednesday Trading	27/03
Evaxion Announces Business Update and Full Year 2023 Financial Results	27/03

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Evaxion Biotech A/S

Aandelen

EVAX

US29970R2040

Andere talen

Filters